Tang, Ziniu
Shi, Fang
Zhu, Kunli
Feng, Rui
Jiang, Shumei
Li, Minghuan
Xu, Lei
Yue, Jinbo
Funding for this research was provided by:
National Natural Science Foundation of China (82272753)
Shandong Provincial Natural Science Foundation (ZR2021LZL002)
Bethune Cancer Radiotherapy Translational Medicine Research Fund (flzh202103)
The Key Research and Development Program of Shandong (2021SFGC05012021)
Article History
Received: 28 February 2025
Accepted: 26 August 2025
First Online: 14 October 2025
Declarations
:
: The Ethics Committee of the Affiliated Cancer Hospital of Shandong First Medical University approved the final protocol (Approval No. SDZLEC2024-414–02) in accordance with the Declaration of Helsinki and Good Clinical Practice principles. All patients will provide written informed consent prior to enrollment.
: Not applicable.
: The authors declare no competing interests.